Literature DB >> 22170584

Rapid synthesis of new DNMT inhibitors derivatives of procainamide.

Ludovic Halby1, Christine Champion, Catherine Sénamaud-Beaufort, Sophie Ajjan, Thierry Drujon, Arumugam Rajavelu, Alexandre Ceccaldi, Renata Jurkowska, Olivier Lequin, William G Nelson, Alain Guy, Albert Jeltsch, Dominique Guianvarc'h, Clotilde Ferroud, Paola B Arimondo.   

Abstract

DNA methyltransferases (DNMTs) are responsible for DNA methylation, an epigenetic modification involved in gene regulation. Families of conjugates of procainamide, an inhibitor of DNMT1, were conceived and produced by rapid synthetic pathways. Six compounds resulted in potent inhibitors of the murine catalytic Dnmt3A/3L complex and of human DNMT1, at least 50 times greater than that of the parent compounds. The inhibitors showed selectivity for C5 DNA methyltransferases. The cytotoxicity of the inhibitors was validated on two tumour cell lines (DU145 and HCT116) and correlated with the DNMT inhibitory potency. The inhibition potency of procainamide conjugated to phthalimide through alkyl linkers depended on the length of the linker; the dodecane linker was the best.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170584     DOI: 10.1002/cbic.201100522

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  15 in total

Review 1.  Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2.

Authors:  Gareth Chin Khye Ang; Amogh Gupta; Uttam Surana; Shirlyn Xue Ling Yap; Reshma Taneja
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

2.  Epigenetic therapy of hematological malignancies: where are we now?

Authors:  Relja Popovic; Mrinal Y Shah; Jonathan D Licht
Journal:  Ther Adv Hematol       Date:  2013-04

3.  Docking of a novel DNA methyltransferase inhibitor identified from high-throughput screening: insights to unveil inhibitors in chemical databases.

Authors:  José L Medina-Franco; Jakyung Yoo
Journal:  Mol Divers       Date:  2013-02-28       Impact factor: 2.943

Review 4.  The Role of DNA Methylation in Renal Cell Carcinoma.

Authors:  Brittany N Lasseigne; James D Brooks
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

5.  Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.

Authors:  Sergio Valente; Yiwei Liu; Michael Schnekenburger; Clemens Zwergel; Sandro Cosconati; Christina Gros; Maria Tardugno; Donatella Labella; Cristina Florean; Steven Minden; Hideharu Hashimoto; Yanqi Chang; Xing Zhang; Gilbert Kirsch; Ettore Novellino; Paola B Arimondo; Evelina Miele; Elisabetta Ferretti; Alberto Gulino; Marc Diederich; Xiaodong Cheng; Antonello Mai
Journal:  J Med Chem       Date:  2014-01-15       Impact factor: 7.446

Review 6.  Augmenting antitumor immune responses with epigenetic modifying agents.

Authors:  Erika Héninger; Timothy E G Krueger; Joshua M Lang
Journal:  Front Immunol       Date:  2015-02-04       Impact factor: 7.561

7.  Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.

Authors:  Jakyung Yoo; Sun Choi; José L Medina-Franco
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

Review 8.  DNA methylation and cancer diagnosis.

Authors:  Yannick Delpu; Pierre Cordelier; William C Cho; Jérôme Torrisani
Journal:  Int J Mol Sci       Date:  2013-07-18       Impact factor: 5.923

Review 9.  Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes.

Authors:  Marloes L de Groote; Pernette J Verschure; Marianne G Rots
Journal:  Nucleic Acids Res       Date:  2012-09-21       Impact factor: 16.971

10.  Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies.

Authors:  Christina Gros; Laura Chauvigné; Anaïs Poulet; Yoann Menon; Frédéric Ausseil; Isabelle Dufau; Paola B Arimondo
Journal:  Nucleic Acids Res       Date:  2013-08-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.